EP1486227B1 - Inhalateur - Google Patents

Inhalateur Download PDF

Info

Publication number
EP1486227B1
EP1486227B1 EP04020854A EP04020854A EP1486227B1 EP 1486227 B1 EP1486227 B1 EP 1486227B1 EP 04020854 A EP04020854 A EP 04020854A EP 04020854 A EP04020854 A EP 04020854A EP 1486227 B1 EP1486227 B1 EP 1486227B1
Authority
EP
European Patent Office
Prior art keywords
inhaler
yoke
cup
medicament
spool
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP04020854A
Other languages
German (de)
English (en)
Other versions
EP1486227A3 (fr
EP1486227A2 (fr
Inventor
Lawrence Keane
David O'leary
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norton Healthcare Ltd
Original Assignee
Norton Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norton Healthcare Ltd filed Critical Norton Healthcare Ltd
Priority to DK10010833.1T priority Critical patent/DK2314336T3/da
Priority to EP10010833.1A priority patent/EP2314336B1/fr
Publication of EP1486227A2 publication Critical patent/EP1486227A2/fr
Publication of EP1486227A3 publication Critical patent/EP1486227A3/fr
Application granted granted Critical
Publication of EP1486227B1 publication Critical patent/EP1486227B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0005—Details of inhalators; Constructional features thereof with means for agitating the medicament
    • A61M15/0006—Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means
    • A61M15/0008—Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means rotating by airflow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
    • A61M15/0048—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged in a plane, e.g. on diskettes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
    • A61M15/007—Mechanical counters
    • A61M15/0071—Mechanical counters having a display or indicator
    • A61M15/0078—Mechanical counters having a display or indicator on a strip
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0086—Inhalation chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0091—Inhalators mechanically breath-triggered
    • A61M15/0093—Inhalators mechanically breath-triggered without arming or cocking, e.g. acting directly on the delivery valve
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0091—Inhalators mechanically breath-triggered
    • A61M15/0096—Hindering inhalation before activation of the dispenser
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06M—COUNTING MECHANISMS; COUNTING OF OBJECTS NOT OTHERWISE PROVIDED FOR
    • G06M1/00—Design features of general application
    • G06M1/04—Design features of general application for driving the stage of lowest order
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06M—COUNTING MECHANISMS; COUNTING OF OBJECTS NOT OTHERWISE PROVIDED FOR
    • G06M1/00—Design features of general application
    • G06M1/22—Design features of general application for visual indication of the result of count on counting mechanisms, e.g. by window with magnifying lens
    • G06M1/24—Drums; Dials; Pointers
    • G06M1/246—Bands; Sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/02—Sprayers or atomisers specially adapted for therapeutic purposes operated by air or other gas pressure applied to the liquid or other product to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0091—Inhalators mechanically breath-triggered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00—Characteristics of a physical parameter; associated device therefor
    • A61M2206/10—Flow characteristics
    • A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows

Definitions

  • the present disclosure relates to an apparatus and method for administering medicament for inhalation by a patient and, more particularly, to a dry powdered medicament inhaler.
  • Metered dose medicament inhalers are well known for dispensing medicament to the lungs of a patient, for treating asthma for example.
  • Existing types of medicament dispensing inhalers include pressurized propellant inhalers, aqueous solution inhalers, and dry-powdered inhalers.
  • U.S. Patent No. 5,503,144 to Bacon shows a dry powdered inhaler.
  • the inhaler includes a reservoir for containing a dry powdered medicament, a metering chamber for removal of the powdered medicament from the reservoir in discrete amounts, and an air inlet for entraining the removed powdered medicament through a mouthpiece upon patient inhalation.
  • U.S. Patent No. 5,971,951 to Ruskewicz shows an inhaler including a motor driven cam mechanism for extruding aqueous medicament through a porous membrane to form a medicament aerosol for inhalation by a patient.
  • the inhaler also includes sensors, circuitry and a microprocessor that determines the rate of patient inhalation and operates the extrusion mechanism only upon adequate inhalation levels.
  • a pressurized propellant, or "aerosol" inhaler is shown in U.S, Patent No. 5,447,150 to Bacon, which also discloses a simple, mechanical actuation assembly for ensuring that medicament is dispensed from the inhaler only upon adequate inhalation by a patient.
  • the actuation assembly works by applying a pre-load to a valve of the aerosol container sufficient to cause a dose release, but prevents the release by applying a pneumatic resisting force. The dose or medicament is then released upon a patient inhalation strong enough to move a door within the assembly, which in turn releases the pneumatic resisting force.
  • the new and improved inhaler for administering medicament for patient inhalation.
  • the new and improved inhaler can be used with dry powdered medicament.
  • the new and improved inhaler will preferably include mechanical assemblies for metering doses of medicament, managing medicament reservoir pressure, and counting the number of doses remaining in the inhaler.
  • WO 94/05359 A discloses a medicament inhaler for dry powdered medicament.
  • the inhaler comprises a yoke for actuating a medicament metering and dispensing mechanism.
  • the inhaler also comprises a cam for moving the position of the yoke.
  • the present invention provides a medicament inhaler according to claim 1.
  • the present disclosure therefore, provides a new and improved medicament inhaler having a unique dose metering system.
  • the inhaler includes a mouthpiece for patient inhalation, a delivery passageway for directing an inhalation induced air flow through the mouthpiece, a channel extending from the delivery passageway, and a reservoir for containing medicament, with the reservoir having a dispenser port connected to the channel.
  • the dose metering system includes a cup received in the channel, which is movable between the dispenser port and the delivery passageway, a cup spring biasing the cup towards one of the dispenser port and the passageway, and a yoke movable between three positions.
  • the yoke includes a ratchet engaging the cup and preventing movement of the cup when the yoke is in one of the two first positions, and allowing movement of the cup when the yoke is in the third of the positions.
  • the present disclosure also provides a medicament inhaler having a unique reservoir pressure system.
  • the inhaler includes a sealed reservoir having a dispenser port, and a channel communicating with the dispenser port, and a cup assembly movably received in the channel.
  • the pressure system includes a pressure relief port in the channel, and a conduit providing fluid communication between an interior of the sealed reservoir and the pressure relief port of the channel.
  • the cup assembly includes a recess adapted to receive medicament when aligned with the dispenser port, a first sealing surface adapted to seal the dispenser port when the recess is unaligned with the dispenser port, and a second sealing surface adapted to seal the pressure relief port when the recess is aligned with the dispenser port and unseal the pressure relief port when the recess is unaligned with the dispenser port.
  • the present disclosure additionally provides a medicament inhaler having a unique dose counter.
  • the inhaler includes a mouthpiece for patient inhalation, a dose metering system including a pawl movable along a predetermined path during the metering of a dose of medicament to the mouthpiece by the dose metering system, and a dose counter.
  • the dose counter includes a bobbin, a rotatable spool, and a rolled ribbon received on the bobbin, rotatable about an axis of the bobbin.
  • the ribbon has indicia thereon successively extending between a first end of the ribbon secured to the spool and a second end of the ribbon positioned on the bobbin.
  • the dose counter also includes teeth extending radially outwardly from the spool into the predetermined path of the pawl so that the spool is rotated by the pawl and the ribbon advanced onto the spool during the metering of a dose to the mouthpiece.
  • the present disclosure provides a new and improved inhaler including a simple, accurate and consistent mechanical dose metering system that dispenses dry powdered medicament in discrete amounts or doses for patient inhalation, a reservoir pressure system that ensures consistently dispensed doses, and a dose counter indicating the number of doses remaining in the inhaler.
  • the present disclosure provides a new and improved inhaler 10 for dispensing a dry-powdered medicament in metered doses for patient inhalation.
  • the inhaler 10 of the present disclosure provides many beneficial features including but not limited to a dose metering system that dispenses dry powdered medicament in discrete amounts or doses for patient inhalation, a medicament reservoir pressure system for managing pressure within the reservoir, and a dose counting system indicating the number of doses remaining in the inhaler 10.
  • the inhaler 10 generally includes a housing 18, and an assembly 12 received in the housing (see FIG. 2 ).
  • the housing 18 includes a case 20 having an open end 22 and a mouthpiece 24 for patient inhalation, a cap 26 secured to and closing the open end 22 of the case 20, and a cover 28 pivotally mounted to the case 20 for covering the mouthpiece 24 (see FIGS. 1, 2 and 9 ).
  • the housing 18 is preferably manufactured from a plastic such as polypropylene, acetal or moulded polystyrene, but may be manufactured from metal or another suitable material.
  • the internal assembly 12 includes a reservoir 14 for containing dry powered medicament in bulk form, a de-agglomerator 32 that breaks down the medicament between a delivery passageway 34 and the mouthpiece 24, and a spacer 38 connecting the reservoir to the de-agglomerator.
  • the reservoir 14 is generally made up of a collapsible bellows 40 and a hopper 42 having an dispenser port 44 (see FIGS. 2-5 and 7-8 ) for dispensing medicament upon the bellows 40 being at least partially collapsed to reduce the internal volume of the reservoir.
  • the hopper 42 is for holding the dry powder medicament in bulk form and has an open end 46 closed by the flexible accordion-like bellows 40 in a substantially air-tight manner.
  • An air filter 48 covers the open end 46 of the hopper 42 and prevents dry powder medicament from leaking from the hopper 42 (see FIG. 7 ).
  • a base 50 of the hopper 42 is secured to a spacer 38, which is in turn secured to the de-agglomerator 32 (see FIGS. 3-5 and 7-8 ).
  • the hopper 42, the spacer 38, and the de-agglomerator 32 are preferably manufactured from a plastic such as polypropylene, acetal or moulded polystyrene, but may be manufactured from metal or another suitable material.
  • the hopper 42, the spacer 38 and the de-agglomerator 32 are connected in a manner that provides an air tight seal between the parts. For this purpose heat or cold sealing, laser welding or ultrasonic welding could be used, for example.
  • the spacer 38 and the hopper 42 together define the medicament delivery passageway 34, which preferably includes a venturi 36 (see FIG. 16 ) for creating an entraining air flow.
  • the spacer 3 8 defines a slide channel 52 communicating with the dispenser port 44 of the hopper 42, and a chimney 54 providing fluid communication between the medicament delivery passageway 34 and a supply port 56 of the de-agglomerator 32 (see FIGS. 7 and 8 ).
  • the slide channel 52 extends generally normal with respect to the axis "A" of the inhaler 10.
  • the de-agglomerator 32 breaks down agglomerates of dry powder medicament before the dry powder leaves the inhaler 10 through the mouthpiece 24.
  • the de-agglomerator includes a swirl chamber 58 extending from the supply port 56 to an outlet port 60 connected to the mouthpiece 24 (see FIG. 16 ).
  • the de-agglomerator 32 also includes two diametrically opposed inlet ports 62 that extend substantially tangential to the circular cross-section of the swirl chamber.
  • Radial vanes 64 are positioned at the top of the swirl chamber and are sized such that at least a portion of breath-actuated air streams entering through the diametrically opposed inlet ports 62 collide with the vanes.
  • the inhaler 10 preferably includes a de-agglomerator of the type disclosed in co-pending provisional U.S. patent application serial no. 60/213,382, filed June 23, 2000 (entitled “De-Agglomerator for Breath-Actuated Dry Powder Inhaler 10"), which has been incorporated herein by reference. It should be understood that although the inhaler 10 of the present disclosure is shown with a particular de-agglomerator 32, the inhaler 10 is not limited to use with the de-agglomerator shown and can be used with other types of de-agglomerators or a simple swirl chamber.
  • the dose metering system includes a first yoke 66 and a second yoke 68 mounted on the internal assembly 12 within the housing 18, and movable in a linear direction parallel with an axis "A" of the inhaler 10 (see FIG. 2 ).
  • An actuation spring 69 is positioned between the cap 26 of the housing 18 and the first yoke 66 for biasing the yokes in a first direction towards the mouthpiece 24.
  • the actuation spring 69 biases the first yoke 66 against the bellows 40 and the second yoke 68 against cams 70 mounted on the mouthpiece cover 28 (see FIG. 9 ).
  • the first yoke 66 includes an opening 72 that receives and retains a crown 74 of the bellows 40 such that the first yoke 66 pulls and expands the bellows 40 when moved towards the cap 26, i.e., against the actuation spring 69 (see FIG. 2 ).
  • the second yoke 68 includes a belt 76, which receives the first yoke 66, and two cam followers 78 extending from the belt in a direction opposite the first yoke 66 (see FIGS. 3 , 11 and 12 ), towards the cams 70 of the mouthpiece cover 28.
  • the dose metering system also includes the two cams 70 mounted on the mouthpiece cover 28 (see FIGS. 9 and 10 ), and movable with the cover 28 between open and closed positions.
  • the cams 70 each include an opening 80 for allowing outwardly extending hinges 82 of the case 20 to pass therethrough and be received in first recesses 84 of the cover 28.
  • the cams 70 also include bosses 86 extending outwardly and received in second recesses 88 of the cover 28, such that the cover 28 pivots about the hinges 82 and the cams 70 move with the cover 28 about the hinges.
  • Each cam 70 also includes first, second and third cam surfaces 90, 92, 94, and the cam followers 78 of the second yoke 68 are biased against the cam surfaces by the actuation spring 69.
  • the cam surfaces 90, 92, 94 are arranged such the cam followers 78 successively engage the first cam surfaces 90 when the cover 28 is closed, the second cam surfaces 92 when the cover 28 is partially opened, and the third cam surfaces 94 when the cover 28 is fully opened.
  • the first cam surfaces 90 are spaced further from the hinges 82 than the second and the third cam surfaces, while the second cam surfaces 92 are spaced further from the hinges 82 than the third cam surfaces 94.
  • the cams 70 therefore, allow the yokes 66, 68 to be moved by the actuation spring 69 parallel with the axis "A" of the inhaler 10 in the first direction (towards the mouthpiece 24) through first, second and third positions as the cover 28 is opened.
  • the cams 70 also push the yokes 66, 68 in a second direction parallel with the axis "A" (against the actuation spring 69 and towards the cap 26 of the housing 18) through the third, the second and the first positions as the cover 28 is closed.
  • the dose metering system further includes a cup assembly 96 movable between the dispenser port 44 of the reservoir 14 and the delivery passageway 34.
  • the cup assembly 96 includes a medicament cup 98 mounted in a sled 100 slidably received in the slide channel 52 of the spacer 38 below the hopper 42 (see FIGS. 5 and 6 ).
  • the medicament cup 98 includes a recess 102 adapted to receive medicament from the dispenser port 44 of the reservoir 14 and sized to hold a predetermined dose of dry powdered medicament when filled.
  • the cup sled 100 is biased along the slide channel 52 from the dispenser port 44 of the hopper 42 towards the delivery passageway 34 by a cup spring 104, which is secured on the hopper 42 (see FIGS. 4 and 5 ).
  • the dose metering system also includes a ratchet 106 and a push bar 108 on one of the cam followers 78 of the second yoke 68 that engage a boss 110 of the cup sled 100 (see FIGS. 5 , 11 and 12 ).
  • the ratchet 106 is mounted on a flexible flap 112 and is shaped to allow the boss 110 of the sled 100 to depress and pass over the ratchet 106, when the boss 110 is engaged by the push bar 108. Operation of the dose metering system is discussed below.
  • the reservoir pressure system includes a pressure relief conduit 114 in fluid communication with the interior of the reservoir 14 (see FIGS. 7 and 8 ), and a pressure relief port 116 in a wall of the slide channel 52 (see FIGS. 5 and 8 ) providing fluid communication with the pressure relief conduit 114 of the hopper 42.
  • the medicament cup assembly 96 includes a first sealing surface 118 adapted to seal the dispenser port 44 upon the cup assembly being moved to the delivery passageway 34 (see FIGS. 5 and 6 ).
  • a sealing spring 120 is provided between the sled 100 and the cup 98 for biasing the medicament cup 98 against a bottom surface of the hopper 42 to seal the dispenser port 44 of the reservoir 14.
  • the cup 98 includes clips 122 that allow the cup to be biased against the reservoir, yet retain the cup in the sled 100.
  • the sled 100 includes a second sealing surface 124 adapted to seal the pressure relief port 116 when the recess 102 of the cup 98 is aligned with the dispenser port 44, and an indentation 126 (see FIG. 6 ) adapted to unseal the pressure relief port 116 when the first sealing surface 118 is aligned with the dispenser port 44. Operation of the pressure system is discussed below.
  • the dose counting system 16 is mounted to the hopper 42 and includes a ribbon 128, having successive numbers or other suitable indicia printed thereon, in alignment with a transparent window 130 provided in the housing 18 (see FIG. 2 ).
  • the dose counting system 16 includes a rotatable bobbin 132, an indexing spool 134 rotatable in a single direction, and the ribbon 128 rolled and received on the bobbin 132 and having a first end 127 secured to the spool 134, wherein the ribbon 128 unrolls from the bobbin 132 so that the indicia is successively displayed as the spool 134 is rotated or advanced.
  • the spool 134 is arranged to rotate upon movement of the yokes 66, 68 to effect delivery of a dose of medicament from the reservoir 14 into the delivery passageway 34, such that the number on the ribbon 128 is advanced to indicate that another dose has been dispensed by the inhaler 10.
  • the ribbon 128 can be arranged such that the numbers, or other suitable indicia, increase or decrease upon rotation of the spool 134.
  • the ribbon 128 can be arranged such that the numbers, or other suitable indicia, decrease upon rotation of the spool 134 to indicate the number of doses remaining in the inhaler 10.
  • the ribbon 128 can be arranged such that the numbers, or other suitable indicia, increase upon rotation of the spool 134 to indicate the number of doses dispensed by the inhaler 10.
  • the indexing spool 134 preferably includes radially extending teeth 136, which are engaged by a pawl 138 extending from one of the cam followers 78 (see FIGS. 3 and 11 ) of the second yoke 68 upon movement of the yoke to rotate, or advance, the indexing spool 134. More particularly, the pawl 138 is shaped and arranged such that it engages the teeth 136 and advances the indexing spool 134 only upon the mouthpiece 24 cover 28 being closed and the yokes 66, 68 moved back towards the cap 26 of the housing 18.
  • the dose counting system 16 also includes a chassis 140 that secures the dose counting system to the hopper 42 and includes shafts 142, 144 for receiving the bobbin 132 and the indexing spool 134.
  • the bobbin shaft 142 is preferably forked and includes radially nubs 146 for creating a resilient resistance to rotation of the bobbin 132 on the shaft 142.
  • a clutch spring 148 is received on the end of the indexing spool 134 and locked to the chassis 140 to allow rotation of the spool 134 in only a single direction (counterclockwise as shown in FIG. 14 ). Operation of the dose counting system 16 is discussed below.
  • FIG. 13 illustrates the relative movements of the boss 110 of the cup sled 100, and the ratchet 106 and the push bar 108 of the second yoke 68 as the mouthpiece cover 28 is opened and closed.
  • the ratchet 106 prevents the cup spring 104 from moving the cup sled 100 to the delivery passageway 34.
  • the dose metering system is arranged such that when the yokes are in the first position, the recess 102 of the medicament cup 98 is directly aligned with the dispenser port 44 of the reservoir 14 and the pressure relief port 116 of the spacer 38 is sealed by the second sealing surface 124 of the cup sled 100.
  • the actuator spring 69 is allowed to move the yokes 66, 68 linearly towards the mouthpiece 24 to the second position and partially collapse the bellows 40 of the medicament reservoir 14.
  • the partially collapsed bellows 40 pressurizes the interior of the reservoir 14 and ensures medicament dispensed from the dispenser port 44 of the reservoir fills the recess 102 of the medicament cup 98 such that a predetermined dose is provided.
  • the ratchet 106 prevents the cup sled 100 from being moved to the delivery passageway 34, such that the recess 102 of the medicament cup 98 remains aligned with the dispenser port 44 of the reservoir 14 and the pressure relief port 116 of the spacer 38 remains sealed by the second sealing surface 124 of the cup assembly 96.
  • the actuator spring 69 is allowed to move the yokes 66, 68 further towards the mouthpiece 24 to the third position.
  • the ratchet 106 disengages, or falls below the boss 110 of the cup sled 100 and allows the cup sled 100 to be moved by the cup spring 104, such that the filled recess 102 of the cup 98 is position in the venturi 36 of the delivery passageway 34 and the dispenser port 44 of the reservoir 14 is sealed by the first sealing surface 118 of the cup assembly 96.
  • the pressure relief port 116 is uncovered by the indentation 126 in the side surface of the sled 100 to release pressure from the reservoir 14 and allow the bellows 40 to further collapse and accommodate the movement of the yokes 66, 68 to the third position.
  • the inhaler 10 is then ready for inhalation by a patient of the dose of medicament placed in the delivery passageway 34.
  • a breath-induced air stream 150 diverted through the delivery passageway 34 passes through the venturi 36, entrains the medicament and carries the medicament into the de-agglomerator 32 of the inhaler 10.
  • Two other breath-induced air streams 152 enter the de-agglomerator 32 through the diametrically opposed inlet ports 62 and combine with the medicament entrained air stream 150 from the delivery passageway 34.
  • the combined flows 154 and entrained dry powder medicament then travel to the outlet port 60 of the de-agglomerator and pass through the mouthpiece 24 for patient inhalation.
  • the mouthpiece cover 28 can be closed.
  • the trigger cams 70 force the yokes 66, 68 upwardly such that the first yoke 66 expands the bellows 40, and the pawl 138 of the second yoke 68 advances the indexing spool 134 of the dose counting system 16 to provide a visual indication of a dose having been dispensed.
  • the cup assembly 96 is forced back to the first position by the pusher bar 108 of the upwardly moving second yoke 68 (see FIG. 13 ) such that the boss 110 of the cup sled 100 is engaged and retained by the ratchet 106 of the second yoke 68.
  • the foregoing detailed description and preferred embodiment are only illustrative of inhalers constructed in accordance with the present disclosure.
  • Various alternatives and modifications to the presently disclosed inhalers can be devised by those skilled in the art without departing from the scope of the present disclosure.
  • the medicament cup could be provided on a rotary sled, advanced by movement of the yokes.
  • the outlet port of the pressure relief could be provided in other locations than the side wall of the slide channel.
  • the dose counting system could be adapted to provide an audible indications in addition to a visual indication of a dispensed dose. Accordingly, the present disclosure is intended to embrace all such alternatives and modifications that fall within the scope of an inhaler as recited in the appended claims.

Claims (16)

  1. Un inhalateur (10) de médicament comportant :
    une embouchure (24) pour permettre au patient d'inhaler ;
    un passage d'administration (34) pour diriger un flux d'air induit par inhalation (150) à travers l'embouchure ;
    un canal (52) s'étendant à partir du passage d'administration ;
    un réservoir (14) destiné à contenir un médicament, le réservoir ayant un port de distribution (44) raccordé au canal ;
    une coupe (98) reçue dans le canal et pouvant être déplacée entre le port de distribution et le passage d'administration ;
    un ressort de coupe (104) inclinant la coupe vers un élément parmi le port de distribution et le passage ; et
    une fourche (68) pouvant être déplacée entre trois positions et comprenant un cliquet (106) adapté pour s'engager dans la coupe et empêcher le déplacement de la coupe du port de distribution (44) du réservoir (14) au passage d'administration (34) quand la fourche est dans une première et une deuxième des trois positions et permettant ledit déplacement de la coupe quand le cliquet est dans une troisième des trois positions, la fourche (68) comprenant de plus un poussoir (108) adapté pour renvoyer la coupe (98) du passage d'administration (34) au port de distribution (44) lorsque la fourche (68) est déplacée de la troisième à la première position ;
    dans lequel l'inhalateur de médicament comporte de plus au moins une came pouvant être déplacée (70) comprenant trois surfaces de came successives (90, 92, 94) ; et
    un ressort (69) inclinant la fourche contre la came de telle sorte que le déplacement de la came amène la fourche à successivement s'engager dans la surface de came et déplacer la fourche entre les trois positions de la fourche.
  2. Un inhalateur (10) selon la revendication 1, dans lequel le ressort de coupe (104) incline la coupe (98) vers le passage d'administration (34).
  3. Un inhalateur (10) selon la revendication 1 ou 2, comportant de plus un capuchon (28) pouvant être déplacé pour ouvrir et fermer l'embouchure (24), dans lequel l'au moins une came (70) est assujettie au capuchon pour pouvoir se déplacer avec lui, grâce à quoi l'ouverture et la fermeture de l'embouchure amènent la fourche (68) à se déplacer entre les trois positions (90, 92, 94) de la fourche.
  4. Un inhalateur (10) selon n'importe laquelle des revendications 1, 2 ou 3, dans lequel la came (70) peut être déplacée par rotation.
  5. Un inhalateur (10) selon n'importe laquelle des revendications 1 à 4, dans lequel le réservoir (14) comprend un volume de médicament en poudre.
  6. Un inhalateur (10) selon n'importe laquelle des revendications 1 à 5, comportant de plus un désagglomérateur (32) entre le passage d'administration et l'embouchure.
  7. Un inhalateur (10) selon n'importe laquelle des revendications 1 à 6, comportant de plus un déclic (138) s'étendant à partir de la fourche (68) :
    un compteur de doses (16) comprenant,
    une bobine (132),
    un tambour pouvant entrer en rotation (134),
    un ruban enroulé (128) reçu sur la bobine et pouvant entrer en rotation sur un axe de la bobine, le ruban ayant sur lui des indications s'étendant successivement entre une première extrémité (127) du ruban assujetti au tambour et une deuxième extrémité du ruban positionné sur la bobine, et
    des dents (136) s'étendant de façon radiale vers l'extérieur à partir du tambour dans une trajectoire prédéterminée du déclic durant le déplacement de la fourche entre les au moins deux positions, de façon à ce que le tambour soit mis en rotation par le déclic et que le ruban soit avancé sur le tambour durant le déplacement de la coupe.
  8. Un inhalateur (10) selon la revendication 7, dans lequel le tambour (134) entre en rotation dans une seule direction.
  9. Un inhalateur (10) selon la revendication 7 ou 8, dans lequel le compteur de doses (16) comprend un ressort d'embrayage (148) assujetti au tambour (134) et permettant la rotation du tambour dans une seule direction.
  10. Un inhalateur (10) selon n'importe laquelle des revendications 7 à 9, dans lequel les indications comportent des numéros.
  11. Un inhalateur (10) selon n'importe laquelle des revendications 7 à 10, dans lequel les indications sont fournies sur une surface orientée vers l'extérieur de façon radiale du ruban enroulé (128).
  12. Un inhalateur (10) selon n'importe laquelle des revendications 7 à 11, dans lequel la trajectoire prédéterminée du déclic (138) est linéaire.
  13. Un inhalateur (10) selon n'importe laquelle des revendications 7 à 12, dans lequel le déclic (138) se déplace dans une première et une deuxième direction le long de la trajectoire prédéterminée et est adapté pour s'engager avec les dents (136) et avancer le tambour (134) lors du déplacement dans la deuxième direction.
  14. Un inhalateur (10) selon n'importe laquelle des revendications 7 à 13, comportant de plus un logement (18) contenant le compteur de doses (16) et comprenant une fenêtre transparente (13) sur les indications du ruban.
  15. Un inhalateur (10) selon n'importe laquelle des revendications 7 à 14, dans lequel les indications comportent des numéros agencés pour successivement diminuer à mesure que le ruban est avancé sur le tambour.
  16. Un inhalateur (10) selon n'importe quelle revendication précédente, dans lequel :
    le canal (52) comprend un port de décompression (116) ;
    un conduit fournit une communication fluide entre un intérieur du réservoir (14) et le port de décompression ; et
    la coupe (98) comprend,
    un creux (102) adapté pour recevoir un médicament quand il est aligné avec le port de distribution (44) du réservoir,
    une première surface de fermeture hermétique (118) adaptée pour fermer hermétiquement le port de distribution quand le creux n'est pas aligné avec le port de distribution ; et
    une deuxième surface de fermeture hermétique (124) adaptée pour fermer hermétiquement le port de décompression (116) du canal (52) quand le creux est aligné avec le port de distribution et ouvrir le port de décompression quand le creux n'est pas aligné avec le port de distribution.
EP04020854A 2000-06-23 2001-06-23 Inhalateur Expired - Lifetime EP1486227B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DK10010833.1T DK2314336T3 (da) 2000-06-23 2001-06-23 Medikament-inhalator
EP10010833.1A EP2314336B1 (fr) 2000-06-23 2001-06-23 Inhalateur de medicaments

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21366800P 2000-06-23 2000-06-23
US21338200P 2000-06-23 2000-06-23
US213382P 2000-06-23
US213668P 2000-06-23
EP01948661A EP1330280B1 (fr) 2000-06-23 2001-06-23 Inhalateur de medicaments

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
EP01948661.2 Division 2001-06-23
EP01948661A Division EP1330280B1 (fr) 2000-06-23 2001-06-23 Inhalateur de medicaments

Related Child Applications (2)

Application Number Title Priority Date Filing Date
EP10010833.1A Division EP2314336B1 (fr) 2000-06-23 2001-06-23 Inhalateur de medicaments
EP10010833.1 Division-Into 2010-09-27

Publications (3)

Publication Number Publication Date
EP1486227A2 EP1486227A2 (fr) 2004-12-15
EP1486227A3 EP1486227A3 (fr) 2007-02-21
EP1486227B1 true EP1486227B1 (fr) 2012-03-07

Family

ID=26908022

Family Applications (3)

Application Number Title Priority Date Filing Date
EP01948661A Expired - Lifetime EP1330280B1 (fr) 2000-06-23 2001-06-23 Inhalateur de medicaments
EP10010833.1A Expired - Lifetime EP2314336B1 (fr) 2000-06-23 2001-06-23 Inhalateur de medicaments
EP04020854A Expired - Lifetime EP1486227B1 (fr) 2000-06-23 2001-06-23 Inhalateur

Family Applications Before (2)

Application Number Title Priority Date Filing Date
EP01948661A Expired - Lifetime EP1330280B1 (fr) 2000-06-23 2001-06-23 Inhalateur de medicaments
EP10010833.1A Expired - Lifetime EP2314336B1 (fr) 2000-06-23 2001-06-23 Inhalateur de medicaments

Country Status (16)

Country Link
US (4) US7540282B2 (fr)
EP (3) EP1330280B1 (fr)
JP (3) JP4015943B2 (fr)
KR (3) KR100518723B1 (fr)
AT (2) ATE548062T1 (fr)
AU (2) AU7011301A (fr)
CA (2) CA2407262C (fr)
DE (1) DE60107107T2 (fr)
DK (2) DK2314336T3 (fr)
ES (3) ES2382734T3 (fr)
GB (3) GB2366208B (fr)
PE (3) PE20020074A1 (fr)
PT (3) PT2314336E (fr)
TW (3) TWI224512B (fr)
UY (3) UY26796A1 (fr)
WO (1) WO2002000281A2 (fr)

Families Citing this family (145)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999036115A2 (fr) 1998-01-16 1999-07-22 1263152 Ontario Inc. Dispositif indicateur a utiliser conjointement avec un dispositif distributeur
US6082358A (en) 1998-05-05 2000-07-04 1263152 Ontario Inc. Indicating device for aerosol container
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
GB9920839D0 (en) 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
TWI224512B (en) * 2000-06-23 2004-12-01 Norton Healthcare Ltd Reservoir pressure system for medicament inhaler
ZA200306564B (en) 2001-02-26 2004-10-15 Optinose As Nasal devices.
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
WO2003080149A2 (fr) 2002-03-20 2003-10-02 Mannkind Corporation Appareil d'inhalation
US7004164B2 (en) 2002-03-21 2006-02-28 Trudell Medical International Indicating device for aerosol container
CN100406078C (zh) * 2002-03-22 2008-07-30 克利尼科尔设计有限公司 罐体固定装置
ATE503517T2 (de) * 2002-07-31 2011-04-15 Chiesi Farma Spa Pulverinhalator
US7322352B2 (en) * 2002-09-21 2008-01-29 Aventis Pharma Limited Inhaler
US6883517B2 (en) * 2002-09-30 2005-04-26 Asaf Halamish Downdraft nebulizer
AU2003272935C1 (en) * 2002-10-11 2009-06-25 Otsuka Pharmaceutical Co., Ltd. Powder inhalation device
WO2004041334A2 (fr) * 2002-11-04 2004-05-21 Bang & Olufsen Medicom A/S Dispositif de distribution
GB0226020D0 (en) * 2002-11-07 2002-12-18 Glaxo Group Ltd A holder
GB0226021D0 (en) * 2002-11-07 2002-12-18 Corporate Intellectual Propert A container
US20040177848A1 (en) * 2003-03-12 2004-09-16 Alley Kenneth A. Multi-compartment inhaler
FR2854973B1 (fr) * 2003-05-15 2005-08-19 Valois Sas Compteur de doses pour distributeur de produit fluide.
EP1488819A1 (fr) 2003-06-16 2004-12-22 Rijksuniversiteit te Groningen Inhalateur de poudre sèche et procédé d'inhalation pulmonaire de poudre sèche
US7600512B2 (en) * 2003-07-14 2009-10-13 Vortran Medical Technology 1, Inc. Inhaler with breath actuated dose counter
US7703454B2 (en) * 2003-07-14 2010-04-27 Vortran Medical Technology Inhaler with breath actuated dose counter
GB0323085D0 (en) * 2003-10-02 2003-11-05 Norton Healthcare Ltd Dry powder inhalation apparatus
US7621273B2 (en) 2003-10-28 2009-11-24 Trudell Medical International Indicating device with warning dosage indicator
US7100530B2 (en) * 2003-12-15 2006-09-05 Trudell Medical International, Inc. Dose indicating device
KR101105909B1 (ko) 2004-02-16 2012-01-17 글락소 그룹 리미티드 약품 분배기에 사용되는 카운터
WO2005087299A1 (fr) * 2004-03-10 2005-09-22 Glaxo Group Limited Dispositif de distribution
WO2005102429A1 (fr) 2004-04-21 2005-11-03 Innovata Biomed Limited Inhalateur
GB0409197D0 (en) * 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
DE202004007115U1 (de) * 2004-05-03 2004-07-08 Altana Pharma Ag Blindungsvorrichtung
JP5078014B2 (ja) 2004-08-20 2012-11-21 マンカインド コーポレイション ジケトピペラジン合成の触媒反応
MX2007002189A (es) 2004-08-23 2008-01-11 Mannkind Corp Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos.
US7543582B2 (en) 2004-09-20 2009-06-09 Trudell Medical International Dose indicating device with display elements attached to container
GB0427028D0 (en) 2004-12-09 2005-01-12 Cambridge Consultants Dry powder inhalers
WO2006062448A1 (fr) * 2004-12-10 2006-06-15 Ernst Hörlins Ingenjörsbyrå Ab Inhalateur a doses dote d'un compteur de doses
CA2899340A1 (fr) 2005-01-20 2006-07-27 Trudell Medical International Dispositif de distribution
GB0507100D0 (en) * 2005-04-08 2005-05-11 Team Holdings Uk Ltd Improvements in or relating to inhalers
TWI442951B (zh) 2005-04-14 2014-07-01 Astrazeneca Ab 吸入器計量器
US7219664B2 (en) * 2005-04-28 2007-05-22 Kos Life Sciences, Inc. Breath actuated inhaler
JP4500280B2 (ja) * 2005-06-08 2010-07-14 日立オートモティブシステムズ株式会社 粉末薬剤投与器
GB0518355D0 (en) * 2005-09-08 2005-10-19 Glaxo Group Ltd An inhaler
US7803404B2 (en) 2005-09-14 2010-09-28 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
GB0519151D0 (en) 2005-09-20 2005-10-26 Aventis Pharma Ltd Inhaler
IN2015DN00888A (fr) 2006-02-22 2015-07-10 Mannkind Corp
EP1991295B1 (fr) * 2006-03-03 2016-02-10 3M Innovative Properties Company Appareil de distribution de quantites dosees
GB0605150D0 (en) 2006-03-14 2006-04-26 Glaxo Group Ltd Counter For Use With A Medicament Dispenser
US20070295329A1 (en) * 2006-06-13 2007-12-27 Lieberman Eric A Dose indicator
US8141550B2 (en) * 2006-08-01 2012-03-27 Trudell Medical International Dispensing device
CA2673553C (fr) * 2006-12-22 2014-06-17 Laboratorios Almirall, S.A. Dispositif d'inhalation pour medicaments sous forme de poudre
US8225790B2 (en) 2007-01-02 2012-07-24 Astrazeneca Ab Inhaler 624
DE102007056263A1 (de) * 2007-11-22 2009-05-28 Siegfried Generics International Ag Dosiervorrichtung zur Inhalierung einer pulverförmigen Substanz
ES2394589T3 (es) 2007-12-14 2013-02-04 Aerodesigns, Inc Suministro de productos alimenticios transformables en aerosol
GB0800457D0 (en) * 2008-01-11 2008-02-20 Innovata Biomed Ltd Improvements in or relating to inhalers
US8082873B2 (en) 2008-05-05 2011-12-27 Trudell Medical International Drive mechanism for an indicating device
ES2691401T3 (es) * 2008-05-07 2018-11-27 Map Pharmaceuticals Inc. Contador de dosis y mecanismo de bloqueo
US8181591B1 (en) 2008-05-23 2012-05-22 Trudell Medical International Domed actuator for indicating device
KR101933816B1 (ko) 2008-06-13 2019-03-29 맨카인드 코포레이션 건조 분말 흡입기 및 약물 투여 시스템
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
WO2009155581A1 (fr) * 2008-06-20 2009-12-23 Mannkind Corporation Appareil interactif pour l’établissement en temps réel d’un profil des efforts d’inhalation
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
ES2402241T3 (es) * 2008-10-22 2013-04-30 Trudell Medical International Sistema de suministro de aerosol modular
US8381719B1 (en) 2008-12-22 2013-02-26 Trudell Medical International Medicament delivery system with dose indicator and oversleeve actuator
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
DE202008017185U1 (de) * 2008-12-30 2010-05-12 Siegfried Generics International Ag Dosiervorrichtung
GB0904040D0 (en) * 2009-03-10 2009-04-22 Euro Celtique Sa Counter
PL2405963T3 (pl) 2009-03-11 2014-04-30 Mannkind Corp Urządzenie, układ i sposób pomiaru oporu inhalatora
GB2470550A (en) * 2009-05-19 2010-12-01 Alexander Burnup Adjusting Device Comprising Flexible Member with Indicia .
GB0910537D0 (en) 2009-06-18 2009-07-29 Ivax Pharmaceuticals Ireland Inhaler
BRPI1013154B1 (pt) 2009-06-12 2020-04-07 Mannkind Corp Micropartículas de dicetopiperazina com áreas de superfície específicas definidas, pó seco compreendendo as referidas micropartículas, método para formação das referidasmicropartículas e formação de micropartículas de fumaril diacetopiperazina, uso das referidas micropartículas e sistema de inalação
WO2011008662A1 (fr) * 2009-07-13 2011-01-20 Meadwestvaco Calmar Gmbh Dispositifs de distribution de poudre et procédés d'utilisation de ceux-ci
CA2778698A1 (fr) 2009-11-03 2011-05-12 Mannkind Corporation Appareil et methode de simulation d'efforts d'inhalation
GB0919465D0 (en) * 2009-11-06 2009-12-23 Norton Healthcare Ltd Airflow adaptor for a breath-actuated dry powder inhaler
AU2013231201B2 (en) * 2010-05-18 2015-11-12 Ivax Pharmaceuticals Ireland Dose counters for inhalers, inhalers and shafts thereof
JP5497964B2 (ja) 2010-05-18 2014-05-21 アイバックス ファーマシューティカルズ アイルランド 吸入器のための用量カウンタ、吸入器及びそのシャフト
CN105903109A (zh) * 2010-05-18 2016-08-31 艾瓦克斯医药爱尔兰公司 用于吸入器的剂量计数器、吸入器及其轴
MX359281B (es) 2010-06-21 2018-09-21 Mannkind Corp Sistema y metodos para suministrar un farmaco en polvo seco.
MX353285B (es) 2011-04-01 2018-01-05 Mannkind Corp Paquete de blister para cartuchos farmaceuticos.
WO2012174472A1 (fr) 2011-06-17 2012-12-20 Mannkind Corporation Microparticules de dicétopipérazine de capacité élevée
US9202164B2 (en) 2011-09-26 2015-12-01 Trudell Medical International Dose counter and medication delivery device
IN2014DN03093A (fr) 2011-10-24 2015-05-15 Mannkind Corp
SG10201605800UA (en) 2012-07-12 2016-09-29 Mannkind Corp Dry powder drug delivery system and methods
WO2014066856A1 (fr) 2012-10-26 2014-05-01 Mannkind Corporation Compositions et procédés de vaccin antigrippal inhalable
GB201304784D0 (en) * 2013-03-15 2013-05-01 Euro Celtique Sa Dispenser
KR102499439B1 (ko) 2013-03-15 2023-02-13 맨카인드 코포레이션 미세결정성 디케토피페라진 조성물 및 방법
WO2014174036A1 (fr) * 2013-04-26 2014-10-30 Sanofi Sa Mécanisme pour un dispositif d'administration de médicaments
CA2918369C (fr) 2013-07-18 2021-06-29 Mannkind Corporation Compositions pharmaceutiques en poudre seche stables a la chaleur et procedes
WO2015021064A1 (fr) 2013-08-05 2015-02-12 Mannkind Corporation Appareil d'insufflation et procédés
USD783807S1 (en) * 2013-10-07 2017-04-11 Teva Pharmaceutical Industries Limited Respiratory apparatus
AU355165S (en) * 2013-10-07 2014-04-28 Teva Uk Ltd Respiratory apparatus
AU355175S (en) * 2013-10-07 2014-04-29 Teva Uk Ltd Respiratory apparatus
AU355051S (en) * 2013-10-07 2014-04-16 Teva Uk Ltd Respiratory apparatus
TWD174570S (zh) * 2013-10-07 2016-03-21 泰瓦英國有限公司 呼吸裝置
AU355177S (en) * 2013-10-07 2014-04-29 Teva Uk Ltd Respiratory apparatus
AU355166S (en) * 2013-10-07 2014-04-28 Teva Uk Ltd Respiratory apparatus
KR102364945B1 (ko) 2013-10-07 2022-02-17 테바 브랜디드 파마슈티컬 프로덕츠 알앤디, 인코포레이티드 건조 분말 흡입기
USD783159S1 (en) * 2013-10-07 2017-04-04 Teva Pharmaceutical Industries Limited Respiratory apparatus
USD782648S1 (en) * 2013-10-08 2017-03-28 Teva Pharmaceutical Industries Limited Respiratory apparatus
USD783152S1 (en) * 2013-10-08 2017-04-04 Teva Pharmaceutical Industries Limited Respiratory apparatus
USD782653S1 (en) * 2013-10-08 2017-03-28 Teva Pharmaceutical Industries Limited Respiratory apparatus
AU355204S (en) * 2013-10-08 2014-05-02 Teva Uk Ltd Respiratory apparatus
USD783154S1 (en) * 2013-10-08 2017-04-04 Teva Pharmaceutical Industries Limited Respiratory apparatus
USD783149S1 (en) * 2013-10-08 2017-04-04 Teva Pharmaceutical Industries Limited Respiratory apparatus
AU355203S (en) * 2013-10-08 2014-05-01 Teva Uk Ltd Respiratory apparatus
USD783148S1 (en) * 2013-10-08 2017-04-04 Teva Pharmaceutical Industries Limited Respiratory apparatus
USD783804S1 (en) * 2013-10-08 2017-04-11 Teva Pharmaceutical Industries Limited Respiratory apparatus
USD783155S1 (en) * 2013-10-08 2017-04-04 Teva Pharmaceutical Industries Limited Respiratory apparatus
AU355168S (en) * 2013-10-08 2014-04-29 Teva Uk Ltd Respiratory apparatus
AU355056S (en) * 2013-10-08 2014-04-16 Teva Uk Ltd Respiratory apparatus
AU355164S (en) * 2013-10-08 2014-04-28 Teva Uk Ltd Respiratory apparatus
USD783147S1 (en) * 2013-10-08 2017-04-04 Teva Pharmaceutical Industries Limited Respiratory appartus
AU355172S (en) * 2013-10-08 2014-04-29 Teva Uk Ltd Respiratory Apparatus
USD782647S1 (en) * 2013-10-08 2017-03-28 Teva Pharmaceutical Industries Limited Respiratory apparatus
GB201319265D0 (en) * 2013-10-31 2013-12-18 Norton Waterford Ltd Medicament inhaler
AU356104S (en) * 2013-11-29 2014-06-24 Norton Waterford Ltd Respiratory apparatus
USD769437S1 (en) * 2013-11-29 2016-10-18 Norton (Waterford) Limited Respiratory apparatus
GB201321712D0 (en) * 2013-12-09 2014-01-22 Pharmachemie Bv Dry Powder Inhaler
GB201321717D0 (en) * 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
DE102013021718B4 (de) * 2013-12-20 2017-03-02 Gerresheimer Regensburg Gmbh Kapsel zur Verwendung als Reservoir für eine pharmazeutische, vorzugsweise pulverförmige Zubereitung in einem Inhalator sowie Inhalator dafür
USD752204S1 (en) * 2014-03-10 2016-03-22 Civitas Therapeutics, Inc. Indicator for an inhaler
USD755367S1 (en) * 2014-03-10 2016-05-03 Civitas Therapeutics, Inc. Indicator for an inhaler
USD752734S1 (en) 2014-03-10 2016-03-29 Civitas Therapeutics, Inc. Inhaler grip
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
EP3149661A1 (fr) * 2014-05-28 2017-04-05 Sanofi SA Ensemble pour un mécanisme de compteur pour un dispositif d'administration de médicament et dispositif d'administration de médicament
WO2015191259A1 (fr) 2014-06-13 2015-12-17 Microdose Therapeutx Inc. Communication de dispositif médical
KR102548643B1 (ko) * 2014-08-28 2023-06-27 노턴 (워터포드) 리미티드 흡입기용 순응 보조 모듈
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
DE102014017065B3 (de) * 2014-11-20 2015-11-19 Klaus-Dieter Beller Pulverbehältnis für Pulverinhalatoren
US10058661B2 (en) 2014-12-04 2018-08-28 Norton (Waterford) Limited Inhalation monitoring system and method
MA41378A (fr) 2015-01-20 2017-11-28 Teva Branded Pharmaceutical Prod R & D Inc Inhalateur de poudre sèche comprenant du propionate de fluticasone et du xinafoate de salmétérol
TWI579008B (zh) * 2015-03-06 2017-04-21 崑山科技大學 Drug mist inhalation auxiliaries
MA45569A (fr) 2015-06-03 2019-05-15 Microdose Therapeutx Inc Système de notification de dispositif médical
US10507293B2 (en) 2015-06-24 2019-12-17 Ethicon, Inc. Hemostatic powder delivery devices and methods
USD837365S1 (en) * 2016-06-16 2019-01-01 Koninklijke Philips N.V. Handheld secretion clearance device
GB201615186D0 (en) * 2016-09-07 2016-10-19 3M Innovative Properties Co Energy storage mechanism for an inhaler
USD832997S1 (en) * 2016-10-21 2018-11-06 Norton (Waterford) Limited Inhaler
USD852947S1 (en) * 2016-10-21 2019-07-02 Norton (Waterford) Limited Inhaler
USD832998S1 (en) * 2016-10-21 2018-11-06 Norton (Waterford) Limited Inhaler
KR102539907B1 (ko) 2016-11-18 2023-06-05 노턴 (워터포드) 리미티드 전자 장치를 구비한 약물 전달 기구
EP3506971B1 (fr) * 2016-11-18 2020-07-29 Norton (Waterford) Limited Inhalateur
USD853555S1 (en) * 2017-01-03 2019-07-09 Norton (Waterford) Limited Inhaler
WO2019212442A2 (fr) * 2018-03-16 2019-11-07 Inofab Saglik Teknolojileri Anonim Sirketi Procédé de surveillance d'utilisation d'un inhalateur
USD949324S1 (en) * 2019-07-26 2022-04-19 Lupin Ltd. Inhaler
USD948703S1 (en) * 2019-07-26 2022-04-12 Lupin Ltd. Inhaler
USD948704S1 (en) * 2019-07-26 2022-04-12 Lupin Ltd. Inhaler
USD949323S1 (en) * 2019-07-26 2022-04-19 Lupin Ltd. Inhaler

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8630100D0 (en) 1986-12-17 1987-01-28 Weston T E Pressurised metering dispenser
US5119806A (en) * 1987-05-12 1992-06-09 Glaxo Inc. Inhalation device
GB8917775D0 (en) * 1989-08-03 1989-09-20 Atomic Energy Authority Uk Aerosol inhaler
IT1237118B (it) * 1989-10-27 1993-05-18 Miat Spa Inalatore multidose per farmaci in polvere.
US5113855A (en) * 1990-02-14 1992-05-19 Newhouse Michael T Powder inhaler
US5201308A (en) * 1990-02-14 1993-04-13 Newhouse Michael T Powder inhaler
US5020527A (en) * 1990-02-20 1991-06-04 Texax-Glynn Corporation Inhaler device with counter/timer means
GB9004781D0 (en) * 1990-03-02 1990-04-25 Glaxo Group Ltd Device
GB9015522D0 (en) * 1990-07-13 1990-08-29 Braithwaite Philip W Inhaler
GB9025705D0 (en) * 1990-11-27 1991-01-09 Britains Petite Ltd Powder inhaler
GB9026191D0 (en) 1990-12-01 1991-01-16 Harris Pharma Ltd Breath actuated dispensing device
GB9027234D0 (en) 1990-12-15 1991-02-06 Harris Pharma Ltd An inhalation device
WO1992017231A1 (fr) * 1991-03-28 1992-10-15 Innomed, Inc. Inhalateur microelectronique possedant un compteur et un minuteur
US6029661A (en) * 1991-08-26 2000-02-29 3M Innovative Properties Company Powder dispenser
SE9201411D0 (sv) 1992-05-05 1992-05-05 Astra Ab Dosage inhalator with indicating/interupting means
GB9218937D0 (en) 1992-09-08 1992-10-21 Norton Healthcare Ltd Medicament dispensing device
IL106930A0 (en) * 1992-09-08 1993-12-28 Norton Healthcare Ltd Medicament dispensing device
ES2128550T3 (es) * 1992-12-18 1999-05-16 Schering Corp Inhalador para medicamentos en polvo.
FR2701653B1 (fr) * 1993-02-18 1995-04-07 Valois Dispositif doseur pour l'inhalation de poudre sèche.
GB9314614D0 (en) * 1993-07-14 1993-08-25 Minnesota Mining & Mfg Dry powder inhalers
FI942196A (fi) * 1994-05-11 1995-11-12 Orion Yhtymae Oy Jauheinhalaattori
FR2721106B1 (fr) * 1994-06-10 1996-09-13 Step Compteur de doses pour inhalateurs.
WO1996008284A2 (fr) * 1994-09-16 1996-03-21 Laboratoire Glaxo Wellcome Dispositif d'inhalation
US5544647A (en) * 1994-11-29 1996-08-13 Iep Group, Inc. Metered dose inhalator
US6029659A (en) * 1995-04-17 2000-02-29 Solar Shield Corporation Inhalation device with counter
TR199701665T1 (xx) 1995-06-21 1998-06-22 Asta Med�Ca Aktingesellschaft B�t�nle�ik �l�me cihaz�na sahip farmas�tik toz kartu�u ve toz halinde t�bbi maddeler i�in soluma cihaz�.
FI102875B (fi) * 1995-11-10 1999-03-15 Orion Yhtymae Oy Jauheinhalaattori
CA2392466C (fr) * 1995-12-07 2004-05-04 Jago Research Ag Inhalateur pour administrer de multiple doses d'une poudre seche pharmacologique
US5833066A (en) * 1996-01-02 1998-11-10 Inhalermate, Llc Carrying case for oral and nasal inhalation devices with counting mechanism
BR9707660A (pt) * 1996-02-21 2001-10-30 Schering Corp Inalador de medicação em pó
GB2320489A (en) * 1996-12-20 1998-06-24 Norton Healthcare Ltd Inhaler dose counter
GB9700226D0 (en) 1997-01-08 1997-02-26 Glaxo Group Ltd Inhalation device
SE9700940D0 (sv) * 1997-03-14 1997-03-14 Astra Ab Powder inhaler IV
EP0984805B1 (fr) * 1997-05-23 2004-11-10 PA Knowledge Limited Mecanisme d'inhalation
TW533865U (en) * 1997-06-10 2003-05-21 Glaxo Group Ltd Dispenser for dispensing medicament and actuation indicating device
US5855564A (en) 1997-08-20 1999-01-05 Aradigm Corporation Aerosol extrusion mechanism
US6142339A (en) * 1998-01-16 2000-11-07 1263152 Ontario Inc. Aerosol dispensing device
GB9807558D0 (en) * 1998-04-09 1998-06-10 Bason Neil P An indicator device
US6082358A (en) * 1998-05-05 2000-07-04 1263152 Ontario Inc. Indicating device for aerosol container
US6336453B1 (en) * 1999-04-30 2002-01-08 Trudell Medical International Indicating device for aerosol container
WO2000001612A2 (fr) * 1998-07-06 2000-01-13 Iep Group, Inc. Compteur pour distributeur de fluide
TWI224512B (en) * 2000-06-23 2004-12-01 Norton Healthcare Ltd Reservoir pressure system for medicament inhaler
FR2811576B1 (fr) * 2000-07-13 2003-01-24 Henri Bocquee Disposits ou appareils d'administration de produits actifs pulverurents du type medicaments ou vaccins, par voie pulmonaire

Also Published As

Publication number Publication date
PT2314336E (pt) 2014-10-29
JP2007289716A (ja) 2007-11-08
GB2366208B (en) 2004-10-13
EP2314336A2 (fr) 2011-04-27
DE60107107D1 (de) 2004-12-16
CA2552468C (fr) 2008-02-19
EP1330280A2 (fr) 2003-07-30
PE20020074A1 (es) 2002-02-05
PE20020075A1 (es) 2002-02-05
US20020078950A1 (en) 2002-06-27
GB0115519D0 (en) 2001-08-15
UY26795A1 (es) 2002-01-31
JP4015943B2 (ja) 2007-11-28
UY26796A1 (es) 2002-01-31
DE60107107T2 (de) 2005-11-03
EP2314336B1 (fr) 2014-08-20
KR100517900B1 (ko) 2005-10-04
EP1486227A3 (fr) 2007-02-21
JP4897570B2 (ja) 2012-03-14
CA2407262C (fr) 2007-08-28
GB2365778A (en) 2002-02-27
PT1486227E (pt) 2012-04-10
WO2002000281A3 (fr) 2003-01-03
EP2314336A3 (fr) 2013-07-10
GB0115518D0 (en) 2001-08-15
EP1330280B1 (fr) 2004-11-10
CA2407262A1 (fr) 2002-01-03
ES2520966T3 (es) 2014-11-12
KR100518721B1 (ko) 2005-10-05
PE20020163A1 (es) 2002-03-04
US6718972B2 (en) 2004-04-13
CA2552468A1 (fr) 2002-01-03
ES2233659T3 (es) 2005-06-16
DK1486227T3 (da) 2012-04-02
TWI224514B (en) 2004-12-01
GB2366208A (en) 2002-03-06
GB2365778B (en) 2004-10-13
TWI224512B (en) 2004-12-01
KR20030066328A (ko) 2003-08-09
GB2365779A (en) 2002-02-27
KR20050039884A (ko) 2005-04-29
ATE548062T1 (de) 2012-03-15
US7540282B2 (en) 2009-06-02
TWI224513B (en) 2004-12-01
GB2365779B (en) 2004-09-29
PT1330280E (pt) 2005-04-29
EP1486227A2 (fr) 2004-12-15
US6701917B2 (en) 2004-03-09
ES2382734T3 (es) 2012-06-13
GB0115525D0 (en) 2001-08-15
ATE281861T1 (de) 2004-11-15
AU7011301A (en) 2002-01-08
US20090178678A1 (en) 2009-07-16
AU2001270113B2 (en) 2004-08-12
KR20050048687A (ko) 2005-05-24
WO2002000281A2 (fr) 2002-01-03
US20020078949A1 (en) 2002-06-27
JP2007252946A (ja) 2007-10-04
UY26794A1 (es) 2002-01-31
US8006690B2 (en) 2011-08-30
JP4897569B2 (ja) 2012-03-14
JP2004501685A (ja) 2004-01-22
DK2314336T3 (da) 2014-11-03
US20020073996A1 (en) 2002-06-20
KR100518723B1 (ko) 2005-10-05

Similar Documents

Publication Publication Date Title
EP1486227B1 (fr) Inhalateur
AU2001270113A1 (en) Medicament inhaler
US7779839B2 (en) Fluid product dispensing device
US8020554B2 (en) Opening device for fluid product dispensing device
US7878196B2 (en) Fluid product dispensing device
US8087411B2 (en) Fluid product dispensing device
US20110120467A1 (en) Powder inhalation device

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040902

AC Divisional application: reference to earlier application

Ref document number: 1330280

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

AKX Designation fees paid

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AXX Extension fees paid

Extension state: RO

Payment date: 20040902

Extension state: MK

Payment date: 20040902

Extension state: AL

Payment date: 20040902

Extension state: LV

Payment date: 20040902

Extension state: LT

Payment date: 20040902

Extension state: SI

Payment date: 20040902

17Q First examination report despatched

Effective date: 20071031

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NORTON HEALTHCARE LIMITED

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AC Divisional application: reference to earlier application

Ref document number: 1330280

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 548062

Country of ref document: AT

Kind code of ref document: T

Effective date: 20120315

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: NL

Ref legal event code: T3

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

REG Reference to a national code

Ref country code: PT

Ref legal event code: SC4A

Free format text: AVAILABILITY OF NATIONAL TRANSLATION

Effective date: 20120327

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 60146241

Country of ref document: DE

Effective date: 20120503

REG Reference to a national code

Ref country code: GR

Ref legal event code: EP

Ref document number: 20120400719

Country of ref document: GR

Effective date: 20120417

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2382734

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20120613

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120307

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120630

26N No opposition filed

Effective date: 20121210

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 60146241

Country of ref document: DE

Effective date: 20121210

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120623

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 16

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 17

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FI

Payment date: 20190620

Year of fee payment: 19

Ref country code: NL

Payment date: 20190619

Year of fee payment: 19

Ref country code: IE

Payment date: 20190621

Year of fee payment: 19

Ref country code: IT

Payment date: 20190624

Year of fee payment: 19

Ref country code: DK

Payment date: 20190621

Year of fee payment: 19

Ref country code: PT

Payment date: 20190618

Year of fee payment: 19

Ref country code: DE

Payment date: 20190619

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20190619

Year of fee payment: 19

Ref country code: SE

Payment date: 20190619

Year of fee payment: 19

Ref country code: GR

Payment date: 20190621

Year of fee payment: 19

Ref country code: TR

Payment date: 20190618

Year of fee payment: 19

Ref country code: BE

Payment date: 20190619

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20190619

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20190719

Year of fee payment: 19

Ref country code: AT

Payment date: 20190621

Year of fee payment: 19

Ref country code: GB

Payment date: 20190619

Year of fee payment: 19

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 60146241

Country of ref document: DE

REG Reference to a national code

Ref country code: FI

Ref legal event code: MAE

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

Effective date: 20200630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200623

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: NL

Ref legal event code: MM

Effective date: 20200701

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 548062

Country of ref document: AT

Kind code of ref document: T

Effective date: 20200623

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20200623

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20200630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200630

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200630

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210111

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200623

Ref country code: PT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210125

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200701

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200630

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200623

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200624

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200623

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200630

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210101

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200630

REG Reference to a national code

Ref country code: SE

Ref legal event code: EUG

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200623

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20211103

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20210701

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200624

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200623